Recently visited unit
name Price (yuan) Rise and fall
The following are popular stocks
Please check the self selected shares first
join remind View in APP

Hendy Pharmaceutical (301211.SZ)

Questioning stocks
@change@
@changeP@
@now@
Limit: @ up_limit@
Limit: @ down_limit@
Suspension
@date@ @time@
Temporary suspension
Today: @open@ Volume: @volume@ Amplitude: @swing@
Maximum: @high@ Turnover: @amount@ turnover rate: @turnover@
Minimum: @low@ Total Market Value: @fixTotalShare@ P/B ratio: @pb@
Received yesterday: @preClose@ Circulation value: @cvs@ P/E ratio TTM @pe@
Total share capital: @zgb@ Circulating shares: @ltgb@
Information mine:
    The browser version is too low to view the multi null inversion

    Your browser version is too low to view empty data. It is recommended to use IE10 (including) above Firefox Google

    Time-sharing
    Day K
    Week K
    Month K
    K line
    Reinstatement K line
    Technical drawings
    Also concerned:
      5th gear disc opening
      Live broadcast of famous teachers
      Commission ratio -- Abandonment --
      Selling ⑤ -- --
      Sell ④ -- --
      Selling ③ -- --
      Sell ② -- --
      Selling ① -- --
      deal --
      Buy ① -- --
      Buy ② -- --
      Buy ③ -- --
      Buy ④ -- --
      Buy ⑤ -- --
      Outer disc -- Inner disc --

      In case of a key big order, the main force may**

      Quickly use level2 to view details>
      time Price (yuan) Measurement (hand) nature
      time Price (yuan) Measurement (hand) nature
      Transaction price (yuan) Trading volume (hand) Proportion (%)
      time Transaction price (yuan) Trading volume (hand)
      Product entry: Sina Finance APP - Stocks - Investment Research Report
      Product entrance: Sina Finance APP - stock - free question
      Product entrance: Sina Finance APP - stock - free question
      Main and retail investors' capital flow
      Main buy Main sales Purchase by retail investors Retail sales
      Amount (10000 yuan) @mainIn@ @mainOut@ @retailIn@ @retailOut@
      proportion @mainInP@ @mainOutP@ @retailInP@ @retailOutP@
      Loose bill
      Small order
      Large order
      Extra large order
      Net inflow of classified funds
      Loose bill Small order Large order Extra large order
      Net inflow (10000 yuan) @r3_r_in@ @r2_r_in@ @r1_r_in@ @r0_r_in@
      Proportion in the flow board @r3_p_svs@ @r2_p_svs@ @r1_p_svs@ @r0_p_svs@
      Proportion in turnover rate @r3_p_turnover@ @r2_p_turnover@ @r1_p_turnover@ @r0_p_turnover@
      title click reply Final reply

      Company research

      Hot data

      more
      Adjacent ranking
      Top 10 in the industry

      Financial ratios

      more
      Adjacent ranking
      Top 10 in the industry

      Investment rating of research institutions

      more

      In the last 60 days Hendy Pharmaceutical (sz301211) rating was released in three research reports, and the comprehensive rating is as follows:

      Hot columns

      Industry comparison

      name Price (yuan)

      corporate name:

      Hubei Hendy Pharmaceutical Co., Ltd

      Main business:

      R&D, production and sales of chemical APIs and preparations.

      Telephone: 0724-2223339

      Fax: 0724-2223303

      Date of establishment: 1995-12-29

      Listing date: 2021-12-22

      Legal representative: Cheng Zhigang

      general manager: Beam group

      Registered capital: 288 million yuan

      Issue price: 25.800 yuan

      Latest total share capital: 288 million shares

      Latest outstanding shares: 10000 shares

      Segment: Shenzhen Composite Index Shenzhen A-share Shanghai and Shenzhen A-share GEM Shenzhen Stock Connect Shenzhen Stock Connect Pharmaceutical Biology Chemical pharmacy Pharmaceutical Biology API Small disk Margin trading

      2025-03
      2024-12
      2024-09
      2024-06
      2024-03
      Earnings per share 0.0359 yuan 0.3179 yuan 0.2592 yuan 0.2378 yuan 0.1298 yuan
      net asset value per share 8.0587 yuan 8.0198 yuan 7.9702 yuan 7.9452 yuan 8.3157 yuan
      Net operating cash flow per share 0.0210 yuan 0.3336 yuan 0.1700 yuan 0.1110 yuan 0.0498 yuan
      Return on net assets 0.44% 3.96% 3.25% 2.99% 1.56%
      Undistributed profit per share 0.7565 yuan 0.7207 yuan 0.6897 yuan 0.6683 yuan 1.0402 yuan
      Capital reserve per share 6.0990 yuan 6.0990 yuan 6.0990 yuan 6.0990 yuan 6.0990 yuan
      Date of announcement Allocation scheme
      2025-05-17 10 pies 2.5 yuan
      2024-05-18 RMB 4.8 for 10 pies
      2023-05-24 10 pairs4 yuan to 2 shares
      2022-06-28 10 pies, 3 yuan
      2025-03
      2024-12
      2024-09
      Name of shareholders Shareholding (%) Increase or decrease
      Li Xuehong two point three five seven Overweight
      Chen Songzhao one point four five nine reduce one's shares in a listed company
      Wu Xiuyue one point one eight four Overweight
      HKSCC has .. zero point nine eight three Overweight
      He Xueyu zero point seven five three New progress
      Chen Weien zero point seven two nine New progress
      Zhang Yi zero point six six one Overweight
      Huang Chenghuai zero point five six four Unchanged
      Pei Yongquan zero point five five zero New progress
      Ma Shaowei zero point five four six New progress

      Shareholding ratio of circulating shareholders



      user name:
      Password: